Total Payments
$6,269
2024 Payments
$995.11
Companies
51
Transactions
229
Medicare Patients
3,846
Medicare Billing
$389,524
Payment Breakdown by Category
Food & Beverage$6,022 (96.1%)
Education$246.44 (3.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,022 | 220 | 96.1% |
| Education | $246.44 | 9 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $529.84 | 24 | $0 (2024) |
| Astellas Pharma US Inc | $519.16 | 19 | $0 (2023) |
| Intuitive Surgical, Inc. | $496.18 | 3 | $0 (2019) |
| Rochester Medical Corporation | $428.87 | 14 | $0 (2022) |
| Janssen Biotech, Inc. | $360.20 | 20 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $294.97 | 13 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $286.88 | 13 | $0 (2024) |
| C. R. Bard, Inc. & Subsidiaries | $229.83 | 3 | $0 (2023) |
| PFIZER INC. | $224.23 | 14 | $0 (2024) |
| EDAP TECHNOMED INC | $204.02 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $995.11 | 33 | Astellas Pharma Global Development ($131.61) |
| 2023 | $804.26 | 21 | EDAP TECHNOMED INC ($204.02) |
| 2022 | $596.54 | 30 | Astellas Pharma US Inc ($84.49) |
| 2021 | $71.30 | 3 | BOSTON SCIENTIFIC CORPORATION ($39.11) |
| 2020 | $267.13 | 17 | Coloplast Corp ($34.29) |
| 2019 | $864.65 | 35 | C. R. BARD, INC. & SUBSIDIARIES ($182.13) |
| 2018 | $1,481 | 42 | Intuitive Surgical, Inc. ($428.57) |
| 2017 | $1,189 | 48 | AbbVie, Inc. ($297.25) |
All Payment Transactions
229 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/12/2024 | Baxter Healthcare | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $36.06 | General |
| Category: Surgical Care | ||||||
| 10/29/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $121.57 | General |
| Category: Urology | ||||||
| 10/24/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diagnostic Imaging | ||||||
| 10/23/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: Oncology | ||||||
| 10/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/24/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/17/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/11/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Oncology | ||||||
| 09/02/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: UROLOGY | ||||||
| 08/28/2024 | Astellas Pharma Global Development | Xtandi (Drug) | Food and Beverage | In-kind items and services | $131.61 | General |
| Category: Oncology | ||||||
| 08/21/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Continence Care | ||||||
| 07/24/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/17/2024 | 180 Medical, Inc. | GENTLECATH GLIDE (Device) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: CONTINENCE CARE | ||||||
| 07/17/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: UROLOGY | ||||||
| 06/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $32.35 | General |
| Category: Oncology | ||||||
| 06/19/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: UROLOGY | ||||||
| 06/05/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 06/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/29/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $36.40 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 05/22/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Immunotherapy | ||||||
| 05/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 636 | 791 | $230,522 | $50,802 |
| 2022 | 20 | 972 | 1,390 | $500,062 | $109,707 |
| 2021 | 25 | 1,204 | 1,683 | $561,175 | $128,277 |
| 2020 | 17 | 1,034 | 1,518 | $453,761 | $100,738 |
Total Patients
3,846
Total Services
5,382
Medicare Billing
$389,524
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 190 | 208 | $37,550 | $11,311 | 30.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 13 | 75 | $93,180 | $10,542 | 11.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 101 | $26,220 | $8,400 | 32.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 38 | 40 | $26,020 | $6,948 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $22,223 | $6,342 | 28.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $5,478 | $1,944 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $6,529 | $1,866 | 28.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 17 | $2,713 | $1,064 | 39.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 22 | $1,915 | $856.43 | 44.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 80 | 90 | $5,850 | $706.24 | 12.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 100 | 129 | $1,409 | $436.99 | 31.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 15 | $1,435 | $386.23 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 278 | 356 | $62,300 | $20,932 | 33.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 15 | 145 | $194,590 | $20,522 | 10.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 197 | $49,053 | $17,856 | 36.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 63 | 77 | $49,665 | $13,907 | 28.0% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2022 | 13 | 13 | $33,215 | $7,419 | 22.3% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2022 | 18 | 31 | $24,180 | $6,338 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $19,855 | $5,610 | 28.3% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 13 | 15 | $19,185 | $4,717 | 24.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 28 | $7,980 | $2,971 | 37.2% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 13 | 19 | $10,309 | $1,860 | 18.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 24 | $3,720 | $1,348 | 36.2% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 13 | 13 | $5,499 | $1,191 | 21.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $3,081 | $1,072 | 34.8% |
About Dr. Robin Lee, MD
Dr. Robin Lee, MD is a Urology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801098405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robin Lee, MD has received a total of $6,269 in payments from pharmaceutical and medical device companies, with $995.11 received in 2024. These payments were reported across 229 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($6,022).
As a Medicare-enrolled provider, Lee has provided services to 3,846 Medicare beneficiaries, totaling 5,382 services with total Medicare billing of $389,524. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Seattle, WA
- Active Since 06/05/2007
- Last Updated 01/19/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1801098405
Products in Payments
- Da Vinci Surgical System (Device) $496.18
- Lupron (Drug) $362.95
- XIAFLEX (Biological) $257.87
- Xtandi (Drug) $212.89
- Erleada (Drug) $212.55
- FIRMAGON (Drug) $173.71
- UROLIFT (Device) $166.41
- XTANDI (Drug) $149.59
- PROVENGE (Drug) $143.70
- ELIGARD (Drug) $141.23
- Myrbetriq (Drug) $125.65
- Prolia (Biological) $125.22
- TOVIAZ (Drug) $123.66
- Optilume BPH Drug Coated Balloon Catheter (Device) $121.57
- Olympus Stents (Device) $116.97
- JELMYTO (Drug) $111.48
- ORGOVYX (Drug) $106.37
- Nubeqa (Drug) $104.38
- AVEED (Biological) $104.14
- ERLEADA (Drug) $103.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Seattle
Dr. James Porter, M.d, M.D
Urology — Payments: $764,015
Urology $764,015
Cristopher Garlitz, M.d, M.D
Urology — Payments: $303,210
Urology $303,210
Dr. Thomas Walsh, M.d, M.D
Urology — Payments: $279,672
Urology $279,672
Marah Hehemann, M.d, M.D
Urology — Payments: $264,034
Urology $264,034
Una Lee, M.d, M.D
Urology — Payments: $131,923
Urology $131,923
Alvaro Lucioni, M.d, M.D
Urology — Payments: $57,879
Urology $57,879